Close

Oppenheimer Maintains an 'Outperform' on Questcor Pharma (QCOR); Bringing In The Consultant

August 2, 2012 10:35 AM EDT Send to a Friend
Oppenheimer maintains an 'Outperform' on Questcor Pharmaceuticals (NASDAQ: QCOR) price target of $59.00.

Analyst, Christopher Holterhoff, said, "Following our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login